US corporations are issuing euro-denominated bonds at an unprecedented pace in 2025, capitalizing on cheaper borrowing costs in Europe and a chance to diversify funding amid uncertainty over President Donald Trump’s tariffs, Financial Times reports.
According to Bank of America, American non-financial firms have already issued over €40 billion in so-called Reverse Yankee deals—where US companies raise funds in Europe—by May 9. This figure surpasses the €30 billion issued during the same period last year and puts 2025 on track to break the full-year record of €88 billion set in 2019.
Heavyweights like Alphabet (Google’s parent company), T-Mobile US, and Pfizer have led the way. Alphabet issued €6.75 billion, T-Mobile €2.75 billion, and Pfizer €3.3 billion across four tranches just this week. Analysts attribute this surge to a combination of market volatility, eurozone rate cuts, and strategic financial planning.
Why Europe? Cheaper Money and Strategic Flexibility
The appeal lies in a growing interest rate gap. The European Central Bank recently cut its benchmark rate to 2.25%, while the US Federal Reserve has held its range steady at 4.25%–4.5%. This divergence makes it significantly cheaper for investment-grade US firms to borrow in euros than in dollars. In April, US borrowers paid interest rates two percentage points higher than their European counterparts.
“In a volatile year, global issuers are frontloading their funding,” said JPMorgan’s Marc Lewell, adding that firms want to lock in favorable terms while they last.
Hedging Risks and Diversification
For US firms with significant European operations, issuing debt in euros also offers a natural hedge against currency risk. Recent swings in the euro-dollar exchange rate—from $1.12 in September to $1.01 in February, and back again—have made foreign exchange volatility a key concern. Raising and spending euros locally insulates companies from further currency shocks.
However, for companies repatriating the funds back to the US, currency hedging costs can offset the benefits of lower rates.
Market Shift: Reverse Yankees Take Center Stage
Reverse Yankees now make up 30% of all euro-denominated corporate bond issuance in 2025, according to PwC—up from a typical share of under 20%. For the first time, US companies have overtaken any other nationality as the dominant force in Europe’s non-financial investment-grade bond market.
Barnaby Martin, European credit strategist at BofA, noted the strategic shift: “French companies no longer dominate European corporate issuance… The euro credit market will likely be more sensitive to US political decisions going forward.”
More Than Just Money: Signaling Market Strength
Beyond financial arbitrage, these deals also signal corporate strength. Executing multibillion-euro transactions demonstrates that US firms can access deep, diversified capital markets. “It’s a very powerful signal to send back to the dollar market,” said James Marriott of Wells Fargo. “It shows you’re able to do as big euro trades as dollar trades.”
With US political uncertainty, fluctuating currency markets, and a favorable eurozone rate environment, industry experts expect the flood of Reverse Yankee bonds to continue. As Insight Investment’s Damien Hill put it: “While this opportunity exists, we expect the volume of US issuers borrowing in euros to remain elevated.”
